ClinicalTrialsFinder

Advanced/Metastatic NSCLC Clinical Trials in Shenzhen, Guangdong

1 recruitingShenzhen, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Non-small Cell Lung CancerAdvanced/Metastatic NSCLC
Beijing Biotech48 enrolled1 locationNCT07467863